Commercial ExecutionMay 19, 2026·6 min read

Why Most GCC Brands Fail at Commercial Execution

In the Gulf Cooperation Council (GCC), consumer health and FMCG brands operate in one of the most dynamic and concentrated retail environments in the world. With populations growing, disposable incomes recovering, and modern trade rapidly expanding, the opportunity is immense. Yet, despite aggressive marketing budgets and stunning product launches, a surprising number of brands fail to gain meaningful traction.

Why do so many brands stumble in a region primed for growth? The answer rarely lies in the product itself. More often than not, the failure is rooted in commercial execution.

At ConsumerHealth.me, we believe that your brand is not what you say—it is what the market is willing to choose. When brands fail in the GCC, it is typically because they treat the region as a single monolith, mismanage their distributor relationships, or fail to bridge the gap between high-level strategy and shelf-level execution.

Here is a closer look at why most GCC brands fail at commercial execution, and how leaders can engineer market preference instead.

1. Treating the GCC as a Single Monolith

A brand owner walking into a meeting in Dubai with a "GCC strategy" has already made their first mistake. The GCC is not a single market; it is a collection of distinct countries with varying demographics, retail structures, and consumer behaviors [1].

Treating the region as a monolith leads to misaligned product positioning and wasted budgets. For example, a premium, health-forward functional beverage might find immediate success in the UAE, where the retail infrastructure is built for international brands and consumers are willing to pay a premium for quality and convenience [1]. However, applying that same volume-based strategy in Saudi Arabia—a market driven by a younger, rapidly urbanizing population looking for everyday household staples—will likely result in failure [1].

Successful commercial execution requires market-specific strategies. Brands must align their product positioning with the actual dynamics of the target country, whether that means prioritizing the UAE for premium goods, Saudi Arabia for mass-market scale, or Kuwait and Qatar for functional health products [1].

2. Over-Reliance on Distributor Models

For many consumer health and FMCG companies entering the GCC, appointing a local distributor is the default route to market. However, over-reliance on distributors is a significant risk factor. The biggest risk in GCC FMCG isn't cost; it is distributor dependency.

Many distributor models in the region are built for volume rather than profitability or brand building. When brands export their strategy without building regional trust or committing to long-term partnerships, they often find their products over-distributed without achieving outlet productivity. This leads to empty shelves during critical promotional periods, lost sales, and ultimately, a breakdown in the commercial experience.

Brands that succeed do not just hand over their products and hope for the best. They actively manage their route-to-market, treating distributors as strategic partners rather than mere logistics providers. This involves clear communication, shared KPIs, and a deep understanding of supply chain dynamics from origin to shelf [1].

3. The Strategy-Execution Gap at the Shelf

The most brilliant marketing campaign cannot save a product that is out of stock or poorly merchandised. In the GCC, the shift toward modern trade—such as hypermarkets and convenience stores—has intensified the battle for shelf space.

Winning brands understand that commercial experience turns interest into conversion. Every touchpoint must increase consumer confidence and reduce friction. Yet, many brands fail to detect execution gaps in the field. They might have a solid route-to-market blueprint, but if the product is not available when the consumer is ready to buy, the strategy fails.

This strategy-execution gap often manifests as poor shelf placement, inconsistent pricing across channels, or a failure to capitalize on seasonal demand spikes (such as Ramadan or Hajj) [1]. To close this gap, companies must invest in retail execution discipline, ensuring that their products are not only available but also highly visible and competitively priced.

4. Failing to Engineer Market Preference

Most companies invest in marketing as if attention were the ultimate goal. But in a crowded consumer health market, attention is not enough—preference is. The critical question is: when the moment of decision arrives, do they choose you?

Market preference is engineered through relevance, trust, strategic clarity, and a seamless commercial experience. Brands that fail at execution often speak from the inside out, focusing on their features rather than the visible customer problem or market tension. They fail to build the trust necessary to reduce perceived risk, and their confused strategies lose momentum before reaching the consumer.

The Path to Commercial Excellence

To win in the GCC, consumer health brands must move beyond generic strategies and focus on disciplined commercial execution. This means:

  • Micro-segmenting the market: Understanding the distinct needs of consumers in the UAE, Saudi Arabia, and other GCC nations.
  • Actively managing route-to-market: Building strong, accountable relationships with distributors.
  • Closing the execution gap: Ensuring flawless retail execution at the shelf level.
  • Engineering preference: Aligning strategy, brand, and experience so the market chooses you first.

Are you ready to accelerate your growth in the GCC?

At ConsumerHealth.me, we help businesses align strategy, brand, experience, and commercial execution so the market chooses them first. If your brand is struggling to gain traction or you want to ensure your next market entry is a success, it’s time to take action.

Book a 30-Minute Strategy Diagnostic today. No pitch. No pressure. We will map the gaps between your strategy and execution, identify your highest-impact growth levers, and help you build a roadmap for sustainable commercial success.


Hashtags: #ConsumerHealth #FMCG #GCCMarket #CommercialExecution #MarketStrategy #BrandGrowth #RetailExecution #MiddleEastBusiness #GoToMarket #HenryRosas


References: [1] ASAFI. "You Have a FMCG Product? Which GCC Market Should You Enter before 2030." Available at: https://asafi.com/news/fmcg-product-which-gcc-market-enter-2026/

Written by
Henry Rosas

Fractional CMO and commercial strategy advisor. 30 years across J&J, Unilever, Mundipharma, Strategy Tools, and FacePhi.

More Insights
AI & Strategy

AI Will Not Replace Marketers — But It Will Replace Weak Commercial Teams

Read →
Omnichannel

Why Omnichannel Fails in Healthcare

Read →

Is the market choosing you?

Book a 30-minute strategy diagnostic. No pitch. No pressure.

Book a Strategy Diagnostic